Clinical trial · Interventional
Evaluating Interventions for Breast Cancer Screening in Ghana
EVALUATING THE EFFECTIVENESS OF COMMUNITY HEALTH NURSE-LED AND TEXT MESSAGING INTERVENTIONS TO IMPROVE BREAST CANCER SCREENING IN GHANA: A MULTI-ARM RANDOMISED CONTROLLED TRIAL
NCT07745517CI-TRIAL-00120503not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to implement two interventions to determine the most effective one that can improve Ghanaian women's decision to get their breasts examined by a healthcare professional. The two interventions are (1) a system where community health nurses will be leveraged to educate women on breast cancer screening; (2) a system where women will be sent text messages about breast cancer screening. Both interventions will be carried out over five months. A survey will be conducted before the intervention is introduced. Then, after the sixth month, another survey will be implemented to determine whether there have been changes. Only women who are 25 years or older will be included in the study.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Screening | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Community Health Nurse-Led Breast Cancer Screening Education | Other | — | UNRESOLVED |
| Control Arm - standard of care | Other | — | UNRESOLVED |
| Text Messaging Breast Cancer Screening Educational Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Arm 1
- description
- Participants assigned to this arm will receive a structured community health nurse (CHN)-led breast cancer screening education programme delivered over five months. Trained CHNs will facilitate ten biweekly 60 minute interactive sessions, with each month focusing on a specific theme: understanding breast cancer and screening, risk factors, signs and symptoms, costs and benefits of screening, and building confidence and intention to undergo screening. CHNs will receive standardized training on the study protocol, educational content, and facilitation methods to ensure intervention fidelity. Sessions will incorporate group discussions and culturally appropriate take-home pamphlets to enhance engagement. Attendance will be monitored, post-session reflections conducted, and follow-up phone calls made to participants who miss sessions. Five CHNs will each facilitate five groups of eleven participants.
- interventionNames
- Other: Community Health Nurse-Led Breast Cancer Screening Education
- type
- EXPERIMENTAL
- label
- Arm 2
- description
- Participants assigned to this arm will receive a structured breast cancer screening text messaging programme over five months. Messages will be delivered twice weekly on Wednesdays and Saturdays between 6:00 a.m. and 8:00 p.m. The intervention will cover the same monthly themes as the CHN-led arm to ensure consistency: understanding breast cancer and screening, risk factors, signs and symptoms, costs and benefits of screening, and building confidence and intention to undergo screening. Message content will be evidence-informed and culturally appropriate, drawing on established breast cancer education materials and previous intervention studies. The timing and frequency of message delivery are based on evidence indicating that twice-weekly messaging within these hours enhances participant engagement and message uptake
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Must be a female aged 25 years or older * Must be resident in the Danfa community * Must be someone who can confirm their availability for at least the next eight months after the initiation of the trial Exclusion Criteria: * Males * Females aged \<25 years * Women who are not resident in the study setting * Women who cannot be available for at least the next eight months after the initiation of the trial
References
Publications (8)
- BACKGROUNDXu H, Xu B. Breast cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2023 Dec 30;35(6):565-583. doi: 10.21147/j.issn.1000-9604.2023.06.02. PMID 38204449
- BACKGROUNDSpieth PM, Kubasch AS, Penzlin AI, Illigens BM, Barlinn K, Siepmann T. Randomized controlled trials - a matter of design. Neuropsychiatr Dis Treat. 2016 Jun 10;12:1341-9. doi: 10.2147/NDT.S101938. eCollection 2016. PMID 27354804
- BACKGROUNDShevlin M, Butter S, McBride O, Murphy J, Gibson-Miller J, Hartman TK, Levita L, Mason L, Martinez AP, McKay R, Stocks TV, Bennett KM, Hyland P, Vallieres F, Valiente C, Vazquez C, Contreras A, Peinado V, Trucharte A, Bertamini M, Panzeri A, Bruno G, Granziol U, Mignemi G, Spoto A, Vidotto G, Bentall RP. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic. BMC Psychiatry. 2022 Mar 1;22(1):154. doi: 10.1186/s12888-022-03787-5. PMID 35232409
- BACKGROUNDSarkhani N, Negarandeh R, Heshmatian ME. Investigating the psychometric properties of the Persian version of the attitude scale for cancer screening. BMC Public Health. 2023 Oct 23;23(1):2068. doi: 10.1186/s12889-023-16981-1. PMID 37872519
- BACKGROUNDOkyere J, Ayebeng C, Dickson KS. Clicks and checks: investigating the association between internet usage frequency and women's uptake of clinical breast examination in Ghana. BMC Health Serv Res. 2024 Sep 27;24(1):1113. doi: 10.1186/s12913-024-11576-x. PMID 39334073
- BACKGROUNDHarris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN; REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9. PMID 31078660